182 related articles for article (PubMed ID: 30022604)
1. Patients With Early-Onset Gout and Development of Earlier Severe Joint Involvement and Metabolic Comorbid Conditions: Results From a Cross-Sectional Epidemiologic Survey.
Pascart T; Norberciak L; Ea HK; Guggenbuhl P; Lioté F
Arthritis Care Res (Hoboken); 2019 Jul; 71(7):986-992. PubMed ID: 30022604
[TBL] [Abstract][Full Text] [Related]
2. Comparison Between Early-Onset and Common Gout: A Systematic Literature Review.
Amatucci AJ; Padnick-Silver L; LaMoreaux B; Bulbin DH
Rheumatol Ther; 2023 Aug; 10(4):809-823. PubMed ID: 37335432
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of early- and late-onset gout: A cross-sectional observational study from a Chinese gout clinic.
Zhang B; Fang W; Zeng X; Zhang Y; Ma Y; Sheng F; Zhang X
Medicine (Baltimore); 2016 Nov; 95(47):e5425. PubMed ID: 27893683
[TBL] [Abstract][Full Text] [Related]
4. Early-onset gout.
Pascart T; Ducoulombier V; Jauffret C
Joint Bone Spine; 2024 Feb; 91(5):105704. PubMed ID: 38336273
[TBL] [Abstract][Full Text] [Related]
5. Demographic and clinical features of gout patients in Turkey: a multicenter study.
Öztürk MA; Kaya A; Şenel S; Dönmez S; Balkarlı A; Çobankara V; Erhan Ç; Sayarlıoğlu M; Ugan Y; Tunç ŞE; Pehlivan Y; Kısacık B; Tufan A; Onat AM; Tezcan E; Yıldırım Çetin G; Pamuk ON
Rheumatol Int; 2013 Apr; 33(4):847-52. PubMed ID: 22588430
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
[TBL] [Abstract][Full Text] [Related]
7. Crystal-proven Gout and Characteristic Gout Severity Factors Are Associated with Cardiovascular Disease.
Disveld IJM; Fransen J; Rongen GA; Kienhorst LBE; Zoakman S; Janssens HJEM; Janssen M
J Rheumatol; 2018 Jun; 45(6):858-863. PubMed ID: 29657151
[TBL] [Abstract][Full Text] [Related]
8. Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy.
Latourte A; Bardin T; Clerson P; Ea HK; Flipo RM; Richette P
Arthritis Care Res (Hoboken); 2018 Jun; 70(6):918-924. PubMed ID: 28834411
[TBL] [Abstract][Full Text] [Related]
9. GOSPEL: prospective survey of gout in France. Part I: design and patient characteristics (n = 1003).
Lioté F; Lancrenon S; Lanz S; Guggenbuhl P; Lambert C; Saraux A; Chiarelli P; Delva C; Aubert JP; Ea HK
Joint Bone Spine; 2012 Oct; 79(5):464-70. PubMed ID: 22281230
[TBL] [Abstract][Full Text] [Related]
10. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey.
Khanna PP; Nuki G; Bardin T; Tausche AK; Forsythe A; Goren A; Vietri J; Khanna D
Health Qual Life Outcomes; 2012 Sep; 10():117. PubMed ID: 22999027
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use.
Novak S; Melkonian AK; Patel PA; Kleinman NL; Joseph-Ridge N; Brook RA
Curr Med Res Opin; 2007 Mar; 23(3):623-30. PubMed ID: 17355743
[TBL] [Abstract][Full Text] [Related]
12. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
Bakris GL; Doghramji PP; Keenan RT; Silber SH
Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
[TBL] [Abstract][Full Text] [Related]
13. [Hyperuricemia, gout and cardiovascular diseases].
Murray K; Burkard T
Ther Umsch; 2016; 73(3):141-6. PubMed ID: 27008446
[TBL] [Abstract][Full Text] [Related]
14. Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
Rothenbacher D; Primatesta P; Ferreira A; Cea-Soriano L; Rodríguez LA
Rheumatology (Oxford); 2011 May; 50(5):973-81. PubMed ID: 21228059
[TBL] [Abstract][Full Text] [Related]
15. Elderly-onset gout: a review.
De Leonardis F; Govoni M; Colina M; Bruschi M; Trotta F
Rheumatol Int; 2007 Nov; 28(1):1-6. PubMed ID: 17653719
[TBL] [Abstract][Full Text] [Related]
16. A Study of Metabolic Parameters in Patients with Gout: A Single Center Study from Nepal.
Vaidya B; Baral R; Lama LD; Joshi R; Bhochhibhoya M; Nakarmi S
Endocr Metab Immune Disord Drug Targets; 2021; 21(6):1090-1095. PubMed ID: 32819238
[TBL] [Abstract][Full Text] [Related]
17. GOSPEL 2 - Colchicine for the treatment of gout flares in France - a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age.
Pascart T; Lancrenon S; Lanz S; Delva C; Guggenbuhl P; Lambert C; Aubert JP; Saraux A; Ea HK; Lioté F
Joint Bone Spine; 2016 Dec; 83(6):687-693. PubMed ID: 26919801
[TBL] [Abstract][Full Text] [Related]
18. Severe tophaceous gout. Characterization of low socioeconomic level patients from México.
Vázquez-Mellado J; Cruz J; Guzmán S; Casasola-Vargas J; Lino L; Burgos-Vargas R
Clin Exp Rheumatol; 2006; 24(3):233-8. PubMed ID: 16870088
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of gout patients according to the laterality of nephrolithiasis: A cross-sectional study using helical computed tomography.
Shimizu T; Hori H; Umeyama M; Shimizu K
Int J Rheum Dis; 2019 Apr; 22(4):567-573. PubMed ID: 30485677
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of metabolic syndrome in gout patients in a hospital setting in sub-Saharan Africa.
Doualla-Bija M; Lobe Batchama Y; Moutchia-Suh J; Ama Moor VJ; Kamdem F; Lekpa FK; Luma Namme H
Diabetes Metab Syndr; 2018 Nov; 12(6):1007-1011. PubMed ID: 29980454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
